IronBridge Private Wealth’s Unity Biotechnology UBX Stock Holding History

IronBridge Private Wealth’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30	Closed	–	–	281
2021 Q4	$0	Hold	30	–	–	﹤0.01%	330
2021 Q3	$1K	Hold	30	–	–	﹤0.01%	265
2021 Q2	$1K	Buy	+30	New	+$1.45K	﹤0.01%	268

Other funds holding UBX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

IronBridge Private Wealth's UBX Position: Q1 2022 in Review

IronBridge Private Wealth sold out of Unity Biotechnology (UBX) in Q1 2022, closing a stake of 30 shares.

IronBridge Private Wealth first reported a position in UBX in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 70 funds tracked by Wall St. Rank hold UBX as of Q1 2022.

IronBridge Private Wealth reported no remaining Unity Biotechnology position as of Q1 2022 after selling out during the quarter.
IronBridge Private Wealth sold 30 Unity Biotechnology shares in Q1 2022.
IronBridge Private Wealth first reported a position in Unity Biotechnology in Q2 2021 and held it in 3 quarters.
IronBridge Private Wealth's Unity Biotechnology position peaked at $1K in Q3 2021.
70 funds tracked by Wall St. Rank held Unity Biotechnology as of Q1 2022.

Based on IronBridge Private Wealth's 13F filing for Q1 2022, filed 16 May 2022.